Original Article

You have full text access to this OnlineOpen article

Prognosis of chronic hepatitis c: Results of a large, prospective cohort study†

  1. Claus Niederau M.D.1,*,
  2. Stefan Lange2,
  3. Tobias Heintges1,
  4. Andreas Erhardt1,
  5. Marlies Buschkamp1,
  6. Dietmar Hürter1,
  7. Marek Nawrocki1,
  8. Lothar Kruska3,
  9. Frank Hensel1,
  10. Wolfgang Petry1,
  11. Dieter Häussinger1

Article first published online: 30 DEC 2003

DOI: 10.1002/hep.510280632

Issue

Hepatology

Hepatology

Volume 28, Issue 6, pages 1687–1695, December 1998

Additional Information

How to Cite

Niederau, C., Lange, S., Heintges, T., Erhardt, A., Buschkamp, M., Hürter, D., Nawrocki, M., Kruska, L., Hensel, F., Petry, W. and Häussinger, D. (1998), Prognosis of chronic hepatitis c: Results of a large, prospective cohort study. Hepatology, 28: 1687–1695. doi: 10.1002/hep.510280632

Author Information

  1. 1

    Department of Medicine, Division of Gastroenterology, Hepatology, and Infectious Diseases, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany

  2. 2

    Department of Medical Informatics, Biometrics and Epidemiology, Ruhr-Universität Bochum, Bochum, Germany

  3. 3

    Dr. Stein-Laboratory, Mönchengladbach, Germany

*Department of Internal Medicine, St. Josef-Hospital, Academic Teaching Hospital, Mülheimer Str. 83, 46045 Oberhausen, Germany. Fax: 49-208-837309

  1. †

    Dedicated to Prof. Dr. Georg Strohmeyer on the occasion of his 70th birthday.

Publication History

  1. Issue published online: 30 DEC 2003
  2. Article first published online: 30 DEC 2003
  3. Manuscript Accepted: 3 AUG 1998
  4. Manuscript Received: 10 MAR 1998

Funded by

  • Van-Meeteren-Foundation and the Gottfried-Wilhelm-Leibniz Prize

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (110K)

References

  • 1
    Mattson L, Weiland O, Glaumann H. Long-term follow-up of chronic posttransfusion non-A, non-B hepatitis: clinical and histological outcome. Liver 1988; 8:184–188.MEDLINE
  • 2
    Realdi G, Alberti A, Rugge M, et al. Long-term follow-up of acute and chronic posttransfusion non-A, non-B hepatitis: evidence of progression to liver cirrhosis. Gut 1982; 23:270–275.MEDLINE
  • 3
    DiBisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology 1991; 14:969–974.MEDLINE
    Direct Link:
  • 4
    Seeff LB, Buskell-Bales Z, Wright EC, et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 1992; 327:1906–1911.MEDLINE
  • 5
    Koretz RL, Abbey H, Coleman E, Gitnick G. Non-A, non-B post-transfusion hepatitis: looking back in the second decade. Ann Intern Med 1993; 119:110–115.MEDLINE
  • 6
    Crowe J, Doyle C, Fielding JF, et al. Presentation of hepatitis C in a uniform cohort 17 years from inoculation. Gastroenterology 1995; 108:A1054.
  • 7
    Takahashi M, Yamada G, Miyamoto R, Doi T, Endo H, Tsuji T. Natural history of chronic hepatitis. Am J Gastroenterol 1993; 88:240–243.MEDLINE
  • 8
    Bjoro K, Froland SS, Yun Z, Samdal HH, Haaland T. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated globulin. N Engl J Med 1994; 331:1607–1611.MEDLINE
  • 9
    Tong MJ, El-Farra NS, Reikes AR, Co RL. Clinical outcome after transfusion-associated hepatitis. N Engl J Med 1995; 332:1463–1466.MEDLINE
  • 10
    Tremolda F, Casarin C, Alberti A, Drago C, Tagger A, Ribero ML, Realdi G. Long-term follow-up on non-A, non-B hepatitis posttransfusion hepatitis. J Hepatol 1992; 16:273–281.MEDLINE
  • 11
    Yano M, Kumada H, Kage M, et al. The long-term pathological evolution of chronic hepatitis C. Hepatology 1996; 23:1334–1340.MEDLINE
    Direct Link:
  • 12
    Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349:825–832.MEDLINE
  • 13
    Fattovich G, Giustina G, Degos F, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997; 112:463–472.MEDLINE
  • 14
    Fattovich G, Giustina G, Degos F, et al. Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C. J Hepatol 1997; 27:201–205.MEDLINE
  • 15
    Dienstag J. The natural history of chronic hepatitis C and what we should do about it. Gastroenterology 1997; 112:652–655.
  • 16
    Serfaty L, Poujol A, Chazouilleres O, et al. Risk factors for liver cirrhosis occurrence in patients with chronic HCV infection: a case control study. Hepatology 1996; 24:A151.
  • 17
    Zein NN, Rakela J, Krawitt EL, Reddy KR, Tominaga T, Persing DH. Hepatitis C virus genotypes in the United states: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group. Ann Intern Med 1996; 125:634–639.MEDLINE
  • 18
    Holtzmuller K, Rholl J, Squire O, Sjogren MH. Does ethnic background, gender, or alcohol have a role in clinical severity of hepatitis C (HCV)? Hepatology 1996; 24:A379.
  • 19
    Romeo R, Tommasini MA, Rumi MG, et al. Genotypes in the progression of hepatitis C related cirrhosis and development of hepatocellular carcinoma. Hepatology 1996; 24:A153.
  • 20
    Dusheiko G, Weiss HS, Brown D, et al. Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology 1994; 19:13–18.MEDLINE
    Direct Link:
  • 21
    Tanaka E, Kiyosawas K, Matsushima T, et al. Epidemiology of genotypes of hepatitis C virus in Japanese patients with type C chronic liver disease: a multi-institutional analysis. J Gastroenterol Hepatol 1995; 10:538–545.MEDLINE
    Direct Link:
  • 22
    Nousbaum J-B, Pol S, Nalpas B, Landais P, Berthelot P, Brechot C. Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group. Ann Intern Med 1995; 122:161–168.MEDLINE
  • 23
    Pozzato G, Moretti M, Franzin F, Croce LS, Tiribelli C, Masayu T, Kaneko S. Severity of liver disease with different hepatitis C viral clones [Letter]. Lancet 1991; 338:509.MEDLINE
  • 24
    Ichimura H, Tamura I, Kurimura O, Koda T, Mizuki M, Tuchie H, Kurimura T. Hepatitis C virus genotypes, reactivity to recombinant immunoblot assay 2 antigens and liver disease. J Med Virol 1994; 43:212–215.MEDLINE
    Direct Link:
  • 25
    Silini E, Bono F, Cividini A, et al. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. Hepatology 1995; 21:285–290.MEDLINE
  • 26
    Kobayashi M, Tanaka E, Sodeyama T, Urushihara A, Matsumoto A, Kiyosawa K. The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses. Hepatology 1996; 23:695–699.MEDLINE
    Direct Link:
  • 27
    Zein NN, Abdulkarim AS, Brandhagen D, Therneau T, Persing DH. Chronic hepatitis C infection (HCV) in the U.S.: an insight into the natural history and evidence for a change in the epidemiology of HCV genotypes. Hepatology 1996; 24:A150.
  • 28
    Mangia A, Cascavilla I, Lezzi G, et al. HCV genotypes in patients with liver disease of different stages and severity. J Hepatol 1997; 26:1173–1178.MEDLINE
  • 29
    Pessione F, Degos F, Duchatelle V, et al. Relation between alcohol, viraemia, and histological lesions in chronic hepatitis C virus carriers. Hepatology 1996; 24:A152.
  • 30
    Honda M, Kaneko S, Sakai A, Unoura M, Murakami S, Kobayashi K. Degree of diversity of hepatitis C virus quasispecies and progression of liver disease. Hepatology 1994; 20:1144–1151.MEDLINE
    Direct Link:
  • 31
    Pawlotsky JM, Pellerin M, Roudot-Thoraval F, et al. Relationship between the genetic complexity of the HCV genome, and the epidemiological, clinical and virological characteristics of HCV infection and its response to interferon alfa. Hepatology 1996; 24:A264.
  • 32
    Hagiwara H, Hayashi N, Mita E, Naito M, Kasahara A, Fusamoto H, Kamada T. Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease. Hepatology 1993; 17:545–550.MEDLINE
    Direct Link:
  • 33
    Kato N, Yokosuka O, Hosada K, Ito Y, Ohto M, Omata M. Quantitation of hepatitis C virus by competitive transcription-polymerase chain reaction: increase of the virus in advanced liver disease. Hepatology 1993; 18:16–20.MEDLINE
  • 34
    Gretch D, Corey I, Wilson J, et al. Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia correlates with advanced stage of disease. J Infect Dis 1994; 169:1219–1225.MEDLINE
  • 35
    Simmonds P, Alberti A, Alter HJ, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994; 19:760–762.
    Direct Link:
  • 36
    Landesamt für Datenverarbeitung und Statistik Nordrhein-Westfalen, ed. Beiträge zur Statistik des Landes Nordrhein-Westfalen (Heft 725: Das Gesundheitswesen in Nordrhein-Westfalen 1992), Düsseldorf: 1995.
  • 37
    Armitage P, Berry G. Statistical Methods in Medical Research. 2nd ed. Oxford: Blackwell Scientific Publications. 1987;403–405.
  • 38
    Kaplan EL, Meier P. Nonparametric estimations from incomplete observations. J Am Stat Assoc 1958; 53:457–481.
  • 39
    Takahashi N, Yamada G, Miyamoto R, Doi T, Endo H, Tsuji T. Natural history of chronic hepatitis C. Am J Gastroenterol 1993; 88:240–243.MEDLINE
  • 40
    Vento S, Cainelli F, Concia E. Lack of sustained efficacy of interferon alfa in patients with chronic hepatitis C. Hepatology 1996; 24:A163.
  • 41
    Ikeda K, Saitoh S, Koida I, et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993; 18:47–53.MEDLINE
    Direct Link:
  • 42
    Kasahara A, Hayashi N, Mochizuki K, Kakumu S, Kiyosawa K, Okita K. Risk factors for hepatocellular carcinoma among chronic hepatitis C patients treated with interferon. Hepatology 1996; 24:A397.
  • 43
    DiBisceglie AM. Hepatitis C and hepatocellular carcinoma. Semin Liver Dis 1995; 15:64–69.MEDLINE
  • 44
    De Mitri MS, Pussin K, Baccarini P, et al. HCV-associated liver cancer without cirrhosis. Lancet 1995; 345:413–415.MEDLINE
  • 45
    Nishigushi S, Kuroki T, Nakatani S, et al. Randomised trial of effects of interferon alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 1995; 346:1051–1055.MEDLINE
  • 46
    Mazzella G, Accogli E, Sottili S, et al. Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis. J Hepatol 1996; 24:141–147.MEDLINE
  • 47
    Benvegnu L, Fattovich G, Chemello L, Noventa F, Alberti A. Retrospective analysis of the effect of interferon therapy on hepatocellular carcinoma (HCC) development of cirrhosis. Hepatology 1996; 24:A397.
  • 48
    Okanoue T, Itoh Y, Minami M, et al. Interferon therapy prevents the development of hepatocellular carcinoma in chronic hepatitis C patients? Hepatology 1996; 24:A397.
  • 49
    Sugiura N, Sakai Y, Ebara M, et al. Detection of hepatocellular carcinoma after interferon therapy for chronic hepatitis C—clinical study of 26 cases. J Gastroenterol Hepatol 1996; 11:535–539.MEDLINE
    Direct Link:
  • 50
    Reid AE, Jeffers J, Reddy KR, Aiza J, Shiff ER. Dienstag JL, Liang TJ. Hepatitis C virus genotypes and hepatocellular carcinoma. Hepatology 1994; 20:250A.
  • 51
    Silini E, Bottelli R, Asti M, et al. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study. Gastroenterology 1996; 111:199–205.MEDLINE
  • 52
    Yotsuyanagi H, Koike K, Yasuda K, Moriya K, Hino K, Kurokawa K, Iino S. Hepatitis C virus genotypes and development of hepatocellular carcinoma. Cancer 1995; 76:1352–1355.MEDLINE
    Direct Link:
Get PDF (110K)